Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Novel radial distribution function approach in the study of point mutations: the HIV-1 protease case study (CROSBI ID 280792)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Novak, Jurica ; Grishina, Maria A. ; Potemkin, Vladimir A. Novel radial distribution function approach in the study of point mutations: the HIV-1 protease case study // Future Medicinal Chemistry, 12 (2020), 11; 1025-1036. doi: 10.4155/fmc-2020-0042

Podaci o odgovornosti

Novak, Jurica ; Grishina, Maria A. ; Potemkin, Vladimir A.

engleski

Novel radial distribution function approach in the study of point mutations: the HIV-1 protease case study

Background: Mutations are one of the engines of evolution. Under constant stress pressure, mutations can lead to the emergence of unwanted, drug resistant entities. Methodology: The radial distribution func- tion weighted by the number of valence shell electrons is used to design quantitative structure–activity relationship (QSAR) model relating descriptors with the inhibition constant for a series of wild-type HIV- 1 protease inhibitor complexes. The residuals of complexes with mutant HIV-1 protease were correlated with the energy of the highest occupied molecular orbitals of the residues introduced to enzyme via point mutations. Conclusion: Successful identification of residues Ile3, Asp25, Val32 and Ile50 as the one whose substitution influences the inhibition constant the most, demonstrates the potential of the pro- posed methodology for the study of the effects of point mutations.

drug design ; HIV-1 protease ; inhibitors ; mutations ; QSAR ; radial distribution function ; RDF

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (11)

2020.

1025-1036

objavljeno

1756-8919

1756-8927

10.4155/fmc-2020-0042

Povezanost rada

Farmacija, Interdisciplinarne prirodne znanosti, Kemija

Poveznice
Indeksiranost